Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01518738 · ClinicalTrials.gov registry record · NA

Attention Training

A NA study of Attention, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
94
Enrollment target
1
Study location

NCT01518738: Completed NA study of Attention, sponsored by University of Wisconsin, Madison.

NCT01518738 is a NA study of Attention that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 94 participants, roughly in line with the 90-participant average among 13 other Attention trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01518738, a NA study of Attention, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
94 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to understand whether attention training is effective in moderating mind wandering.

Primary Outcome

mind wandering will be assessed with self-report to intermittent queries such as "just now, was your attention on the present task or unrelated concerns?" Frequency of endorsement will serve as a measure of frequency of mind wandering (ranging in units from 0 - 100% of the time).

Conditions Studied

Interventions

  • BEHAVIORAL breath attention training
  • BEHAVIORAL working memory attention training

Study Locations (1)

Wisconsin

  • University of Wisconsin Brogden Psychology Building - Madison

Trial Details

FieldValue
Enrollment Target 94 participants
Start Date 2012-02
Est. Completion 2012-11
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT01518738 record still lists

NCT01518738 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, roughly in line with the 90-participant average among 13 other Attention trials with a reported enrollment target.

The record links to 1 condition, with Attention appearing as the primary indexed condition, and to 2 interventions - of which breath attention training is the first listed.

NCT01518738 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT01518738 about?

NCT01518738 is a clinical study titled "Attention Training". The purpose of this study is to understand whether attention training is effective in moderating mind wandering.

What is the current status of trial NCT01518738?

This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2012-02. Estimated completion is 2012-11.

What conditions does trial NCT01518738 study?

This clinical trial studies the following conditions: Attention.

What interventions are being tested in trial NCT01518738?

The interventions under investigation include: breath attention training (BEHAVIORAL), working memory attention training (BEHAVIORAL).

Who is sponsoring clinical trial NCT01518738?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01518738 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Attention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01518738's enrollment target sits among peer trials

94 4th of 13 higher than 10 of 13 other Attention trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Attention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03747146 · 94 participants · NA

    Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service

  • NCT04061421 · 94 participants · Phase 1

    Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)

  • NCT04205968 · 94 participants · Phase 2

    Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

  • NCT04464759 · 94 participants · Phase 1

    A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01518738, the US trial registry maintained by the National Library of Medicine. NCT01518738 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.